PAM
PVG Asset Management Portfolio holdings
AUM
$29.4M
This Quarter Return
+0.38%
1 Year Return
+17.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$25.9M
AUM Growth
–
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
79.07%
Holding
37
New
37
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Direxion Daily S&P 500 Bear 1X Shares
SPDN
|
$4.99M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$3.74M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$3.3M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$1.65M |
| 5 |
ProShares UltraShort S&P500
SDS
|
$1.51M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 6.41% |
| 2 | Technology | 3.6% |
| 3 | Financials | 2.92% |
| 4 | Energy | 1.53% |
| 5 | Communication Services | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ford
F
$46.2B
| $160K | 0.62% |
+14,255
| New | +$160K |
|
27
Fortress Biotech
FBIO
$87.8M
| $82.1K | 0.32% |
+95,500
| New | +$82.1K |
|
|
PNNT
28
Pennant Park Investment Corp
PNNT
$469M
| $63.9K | 0.25% |
+11,695
| New | +$63.9K |
|
|
WINT
29
DELISTED
Windtree Therapeutics
WINT
| $56.1K | 0.22% |
+187,060
| New | +$56.1K |
|
|
HEPA
30
DELISTED
Hepion Pharmaceuticals
HEPA
| $54.5K | 0.21% |
+107,915
| New | +$54.5K |
|
|
BLRX
31
BioLineRX
BLRX
$15.5M
| $44.3K | 0.17% |
+47,860
| New | +$44.3K |
|
32
Viking Therapeutics
VKTX
$3.02B
| $40.3K | 0.16% |
+14,810
| New | +$40.3K |
|
|
DWTX
33
Dogwood Therapeutics, Inc. Common Stock
DWTX
$9.4M
| $30.7K | 0.12% |
+80,590
| New | +$30.7K |
|
|
RNTX
34
Rein Therapeutics, Inc. Common Stock
RNTX
$29M
| $24.3K | 0.09% |
+117,600
| New | +$24.3K |
|
35
Outlook Therapeutics
OTLK
$39.5M
| $20.1K | 0.08% |
+16,455
| New | +$20.1K |
|
36
Synlogic
SYBX
$17.4M
| $17.9K | 0.07% |
+18,870
| New | +$17.9K |
|